Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Jialin Gao, Donghua Zhang, Decai Yu
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2021
Precision treatment in advanced hepatocellular carcinoma
10.1016/j.ccell.2024.01.007 · 2024
Liver transplantation as therapy for hepatocellular carcinoma
10.1111/liv.14346 · 2020
Liver transplantation for pediatric liver malignancies
10.1097/lvt.0000000000000470 · 2025
Management of hepatocellular carcinoma recurrence after liver transplantation
10.1016/j.aohep.2021.100654 · 2022
Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
10.1056/nejm199603143341104 · 1996
Beyond the milan criteria for liver transplantation in children with hepatic tumours
10.1016/s2468-1253(17)30084-5 · 2017
Prediction models of hepatocellular carcinoma recurrence after liver transplantation: a comprehensive review
10.3350/cmh.2022.0060 · 2022
Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
10.1111/jgh.16693 · 2024
Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer
10.1007/s12072-023-10594-x · 2024
Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantation
10.1007/s00330-019-06424-0 · 2020
Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation
10.4254/wjh.v11.i1.50 · 2019
Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review
10.12659/aot.895595 · 2016
Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-Related steatohepatitic hepatocellular carcinoma
10.1007/s00330-024-11151-2 · 2025
MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma
10.1007/s00330-023-09864-x · 2023
Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma
2024
MRI proton density fat fraction for estimation of biological characteristics in hepatocellular carcinoma
10.1186/s12880-025-01789-9 · 2025
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
10.1016/j.jhep.2016.10.038 · 2017
The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution
10.21037/tgh.2017.09.05 · 2017
AFP ratio predicts HCC recurrence after liver transplantation
10.1371/journal.pone.0235576 · 2020
Related factors of hepatocellular carcinoma recurrence associated with hyperglycemia after liver transplantation
10.1016/j.transproceed.2020.10.027 · 2021
Elevated preoperative serum gamma-glutamyltranspeptidase predicts poor prognosis for hepatocellular carcinoma after liver transplantation
2016
Noninvasive urinary protein signatures combined clinical information associated with microvascular invasion risk in HCC patients
10.1186/s12916-023-03137-6 · 2023
No additional external references are available.